USPTO serial 79172263
KOMIPHARM
Reviewed by CopyMark Law Group
Reg. 5084132Status 404
- Filing date
- Status date
- Registration date
- Nov 22, 2016
- Examiner
- SCHWAB, MATTHEW DAVID
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with KOMIPHARM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Yoon S. Ham
Yoon S. Ham Hauptman Ham, LLP2318 Mill RoadSuite 1400Alexandria, VA 22314Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Disinfectants for hygiene purposes; Veterinary preparations, namely, pain relief medication, medication for treatment of intestinal bacteria, antioxidants; Deodorizing preparations for household, commercial or industrial use for pet litter boxes, carpets; Household deodorant; Insecticides; Germicides; Insect repellents; Medicines for veterinary purposes, namely, medicines for treatment of porcine circoviral disease, porcine epidemic diarrhea, transmissible gastroenteritis, rotavirus infection pasteurellosis, pleuropneumoniae, classical swine fever, swine erysipelas, swine mycoplasmoses, akabane disease, pasteurellosis, colibacillosis, bovine ephemeral fever, newcastle disease, infectious bronchitis, low pathogenicity avian influenza, infectious bursal disease, salmonellosis, rabies, canine distemper, infectious canine hepatitis, parvovirus infection, coronavirus infection, leptospirosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Antibiotic preparations; Chemotherapeutics; Tumor suppressing agents; Pharmaceutical preparations acting on the central nervous system; Cardiovascular pharmaceutical preparations; Pharmaceutical agents affecting metabolism; Chemical preparations for pharmaceutical purposes, namely, for the treatment of pain and inflammation associated with cancer, the treatment of cancer, the treatment of leukemia and lymphoma, the treatment of metastatic neoplastic diseases, the treatment of brain tumors, cancer stem cell-targeted and drug resistant cancer therapy, the treatment of urogenital cancer and its metastasis; Biological preparations for the treatment of porcine circoviral disease, porcine epidemic diarrhea, transmissible gastroenteritis, rotavirus infection pasteurellosis, pleuropneumoniae, classical swine fever, swine erysipelas, swine mycoplasmoses, akabane disease, pasteurellosis, colibacillosis, bovine ephemeral fever, newcastle disease, infectious bronchitis, low pathogenicity avian influenza, infectious bursal disease, salmonellosis, rabies, canine distemper, infectious canine hepatitis, parvovirus infection, coronavirus infection, leptospirosis | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Komipharm International Co., Ltd.
- Other trademarks owned by Komipharm International Co., Ltd.
- Other trademarks owned by Komipharm International Co., Ltd.
- Other trademarks in Class 005
- Similar marks named KOMIPHARM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 30, 2025 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Nov 30, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| May 23, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 11, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 20, 2024 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Feb 19, 2024 | INPC | INVALIDATION PROCESSED | — |
| Feb 9, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 9, 2023 | C71T | CANCELLED SECTION 71 | — |
| Nov 22, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 25, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 7, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 7, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 22, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 22, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 16, 2016 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 6, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 6, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 17, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 17, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 17, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 2, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 26, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 22, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 22, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 22, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 22, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 21, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 21, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 21, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 21, 2016 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 21, 2016 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 21, 2016 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 28, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 28, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 23, 2016 | ALIE | ASSIGNED TO LIE | — |
| Mar 10, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 26, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 26, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 9, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 18, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 18, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 18, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 17, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 16, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 14, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 10, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |